AbbVie scraps Galapagos deal to focus on own arthritis drug

(Reuters) - AbbVie Inc said one of its experimental drugs improved symptoms of rheumatoid arthritis in mid-stage studies and scrapped plans to buy rights to a similar treatment from Belgium's Galapagos NV.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news